138 related articles for article (PubMed ID: 38594913)
1. Incorporation of vasa previa screening into a routine anomaly scan: A single center cohort study.
Nwandison M; Daly-Jones E; Drought A; Story L; De-Rosnay P; Sebire N; Nyberg D; Oyelese Y
Acta Obstet Gynecol Scand; 2024 Jul; 103(7):1466-1473. PubMed ID: 38594913
[TBL] [Abstract][Full Text] [Related]
2. Systematic screening for vasa previa at the 20-week anomaly scan.
Gross A; Markota Ajd B; Specht C; Scheier M
Acta Obstet Gynecol Scand; 2021 Sep; 100(9):1694-1699. PubMed ID: 34077551
[TBL] [Abstract][Full Text] [Related]
3. Prevention of stillbirth: impact of two-stage screening for vasa previa.
Zhang W; Geris S; Beta J; Ramadan G; Nicolaides KH; Akolekar R
Ultrasound Obstet Gynecol; 2020 May; 55(5):605-612. PubMed ID: 31840871
[TBL] [Abstract][Full Text] [Related]
4. Prenatal diagnosis and postnatal outcome of Type-III vasa previa: systematic review of literature.
Pozzoni M; Sammaria C; Villanacci R; Borgese C; Ghisleri F; Farina A; Candiani M; Cavoretto PI
Ultrasound Obstet Gynecol; 2024 Jan; 63(1):24-33. PubMed ID: 37470694
[TBL] [Abstract][Full Text] [Related]
5. Incidence of and risk indicators for vasa praevia: a systematic review.
Ruiter L; Kok N; Limpens J; Derks JB; de Graaf IM; Mol B; Pajkrt E
BJOG; 2016 Jul; 123(8):1278-87. PubMed ID: 26694639
[TBL] [Abstract][Full Text] [Related]
6. Impact of Universal Vasa Previa Screening With Color Doppler During the OB Ultrasound Anatomy Scan.
Bihun R; Trinidad MC; Packard AT
J Ultrasound Med; 2024 Mar; 43(3):479-487. PubMed ID: 38009660
[TBL] [Abstract][Full Text] [Related]
7. Can we perform a prenatal diagnosis of vasa previa to improve its obstetrical and neonatal outcomes?
Nohuz E; Boulay E; Gallot D; Lemery D; Vendittelli F
J Gynecol Obstet Hum Reprod; 2017 Apr; 46(4):373-377. PubMed ID: 28643667
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound screening and management of vasa previa in Japan.
Furuya N; Sasaki T; Homma C; Hasegawa J; Suzuki N
J Obstet Gynaecol Res; 2020 Jul; 46(7):1084-1089. PubMed ID: 32281219
[TBL] [Abstract][Full Text] [Related]
9. Vasa previa: diagnosis and management.
Swank ML; Garite TJ; Maurel K; Das A; Perlow JH; Combs CA; Fishman S; Vanderhoeven J; Nageotte M; Bush M; Lewis D;
Am J Obstet Gynecol; 2016 Aug; 215(2):223.e1-6. PubMed ID: 26944186
[TBL] [Abstract][Full Text] [Related]
10. Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa.
Melcer Y; Jauniaux E; Maymon S; Tsviban A; Pekar-Zlotin M; Betser M; Maymon R
Am J Obstet Gynecol; 2018 Apr; 218(4):443.e1-443.e8. PubMed ID: 29353034
[TBL] [Abstract][Full Text] [Related]
11. The Rate of Cervical Length Shortening in the Management of Vasa Previa.
Maymon R; Melcer Y; Tovbin J; Pekar-Zlotin M; Smorgick N; Jauniaux E
J Ultrasound Med; 2018 Mar; 37(3):717-723. PubMed ID: 28880409
[TBL] [Abstract][Full Text] [Related]
12. Rethinking Prenatal Screening for Anomalies of Placental and Umbilical Cord Implantation.
Jauniaux E; Silver RM
Obstet Gynecol; 2020 Dec; 136(6):1211-1216. PubMed ID: 33156190
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of ultrasound screening for fetal structural abnormalities during the first and second trimester of pregnancy in low-risk and unselected populations.
Buijtendijk MF; Bet BB; Leeflang MM; Shah H; Reuvekamp T; Goring T; Docter D; Timmerman MG; Dawood Y; Lugthart MA; Berends B; Limpens J; Pajkrt E; van den Hoff MJ; de Bakker BS
Cochrane Database Syst Rev; 2024 May; 5(5):CD014715. PubMed ID: 38721874
[TBL] [Abstract][Full Text] [Related]
14. Vasa previa: Perinatal outcomes in singleton and multiple pregnancies.
Liu N; Hu Q; Liao H; Wang X; Yu H
Biosci Trends; 2021 May; 15(2):118-125. PubMed ID: 33746156
[TBL] [Abstract][Full Text] [Related]
15. How often do we incidentally find a fetal abnormality at the routine third-trimester growth scan? A population-based study.
Drukker L; Cavallaro A; Salim I; Ioannou C; Impey L; Papageorghiou AT
Am J Obstet Gynecol; 2020 Dec; 223(6):919.e1-919.e13. PubMed ID: 32504567
[TBL] [Abstract][Full Text] [Related]
16. Routine ultrasound for fetal assessment before 24 weeks' gestation.
Kaelin Agten A; Xia J; Servante JA; Thornton JG; Jones NW
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014698. PubMed ID: 34438475
[TBL] [Abstract][Full Text] [Related]
17. Vasa Previa Diagnosis, Clinical Practice, and Outcomes in Australia.
Sullivan EA; Javid N; Duncombe G; Li Z; Safi N; Cincotta R; Homer CSE; Halliday L; Oyelese Y
Obstet Gynecol; 2017 Sep; 130(3):591-598. PubMed ID: 28796681
[TBL] [Abstract][Full Text] [Related]
18. Third-trimester fetoscopic ablation therapy for types II and III vasa previa.
Chmait RH; Monson MA; Chon AH; Masri J; Korst LM; Incerpi MH
Am J Obstet Gynecol; 2024 Jan; 230(1):87.e1-87.e9. PubMed ID: 37741533
[TBL] [Abstract][Full Text] [Related]
19. Perinatal Mortality Despite Prenatal Diagnosis of Vasa Previa: A Systematic Review.
Heyborne K
Obstet Gynecol; 2023 Sep; 142(3):519-528. PubMed ID: 37535966
[TBL] [Abstract][Full Text] [Related]
20. Is neonatal risk from vasa previa preventable? The 20-year experience from a single medical center.
Smorgick N; Tovbin Y; Ushakov F; Vaknin Z; Barzilay B; Herman A; Maymon R
J Clin Ultrasound; 2010; 38(3):118-22. PubMed ID: 20091699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
